Preclinical research in Down syndrome : insights for pathophysiology and treatments
Author(s)
Bibliographic Information
Preclinical research in Down syndrome : insights for pathophysiology and treatments
（Progress in brain research, Volume 251）
Academic Press, an imprint of Elsevier, 2020
Available at / 2 libraries
-
No Libraries matched.
- Remove all filters.
Description and Table of Contents
Description
Preclinical Research in Down Syndrome: From Bench to Bedside, Volume 251, the latest release in the Progress in Brain Research series, highlights new advances in the field. Chapters in this updated release include Exploring genetic and epigenetic mechanisms underlying cognitive deficits in Dow syndrome, The trisomy paradox: gene expression dysregulation domains, the Influence of allelic differences in mouse models of Down syndrome, Modelling Down syndrome in cells: From stem cells to organoids, Modelling Down syndrome in animals from the early stage to the new generation of models, Mapping behavioral landscapes in Down syndrome animal models, and more.
Table of Contents
1. Genetic and epigenetic pathways in Down syndrome: Insights to the brain and immune system from humans and mouse modelsY. Eugene Yu, Zhuo Xing, Catherine Do, Annie Pao, Eun Joon Lee, Sharon Krinsky-McHale, Wayne Silverman, Nicole Schupf and Benjamin Tycko2. Influence of allelic differences in Down syndromeRandall J. Roper, Laura Hawley and Charles R. Goodlett3. Modeling Down syndrome in cells: From stem cells to organoidsGillian Gough, Niamh L. O'Brien, Ivan Alic, Pollyanna A. Goh, Yeap Yee Jie, Jurgen Groet, Dean Nizetic and Aoife Murray4. Modeling Down syndrome in animals from the early stage to the 4.0 models and nextMaria del Mar Muniz Moreno, Veronique Brault, Marie-Christine Birling, Guillaume Pavlovic and Yann Herault5. Mapping behavioral landscapes in Down syndrome animal models Maria Martinez de Lagran6. Using mouse models to understand Alzheimer's disease mechanisms in the context of trisomy of chromosome 21Claudia Cannavo, Justin Tosh, Elizabeth M.C. Fisher and Frances K. Wiseman7. Focusing on cellular biomarkers: The endo-lysosomal pathway in Down syndromeAlexandra Botte and Marie-Claude Potier8. Translational validity and implications of pharmacotherapies in preclinical models of Down syndromeNoemi Rueda, Jesus Florez, Mara Dierssen and Carmen Martinez-Cue9. Plasticity as a therapeutic target for improving cognition and behavior in Down syndromeCarmen Martinez-Cue and Mara Dierssen
by "Nielsen BookData"